When is a direct antiglobulin test (direct Coombs test) indicated, how is it performed, and what do positive or negative results imply for diagnosis and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Direct Antiglobulin Test (Direct Coombs Test): Indications, Performance, and Interpretation

Overview

The direct antiglobulin test (DAT) is indicated whenever immune-mediated hemolysis is suspected, and it functions as the critical branching point that separates immune from non-immune causes of red blood cell destruction. 1

Primary Clinical Indications

The DAT should be ordered in the following specific scenarios:

Hemolytic Anemia Evaluation

  • Order DAT immediately when hemolysis is confirmed (elevated LDH, indirect bilirubin, reticulocytes, and decreased haptoglobin) to determine if the mechanism is immune-mediated 1
  • The test detects immunoglobulin (IgG), complement (C3), or both bound to red blood cell membranes in vivo 2, 3

Neonatal Jaundice

  • Strongly recommended in newborns with jaundice if the mother is Rh negative or has no prenatal typing to detect ABO or Rh incompatibility 4
  • Essential for diagnosing hemolytic disease of the newborn 1, 2
  • If mother is group O, Rh positive, DAT on cord blood is optional but close monitoring is recommended 4

Transfusion Reactions

  • Indicated when transfusion-related hemolysis is suspected 3

Drug-Induced Hemolytic Anemia

  • Should be performed when medications known to cause immune hemolysis are being used 3, 5

Thrombotic Microangiopathy Differentiation

  • A negative DAT is diagnostically important in atypical hemolytic uremic syndrome (aHUS), where it helps differentiate non-immune microangiopathic hemolysis from immune-mediated destruction 6, 7

How the Test is Performed

The DAT involves the following technical steps:

  • Patient red blood cells are washed with saline to remove unbound antibodies 8
  • Anti-human globulin reagent (Coombs reagent) is added, which contains antibodies against human IgG and/or complement C3 2, 5
  • If immunoglobulin or complement is coating the red cells, agglutination occurs, indicating a positive result 3, 5
  • Modern variations include solid-phase methods (dot blot) and gel column technology (DiaMed system) that can detect low-affinity antibodies better than traditional tube methods 8, 9

Interpretation of Results

Positive DAT

A positive DAT indicates antibody-coated red blood cells and confirms immune-mediated hemolysis 4, 1

When DAT is positive with concurrent anemia and reticulocytosis:

  • Confirms autoimmune hemolytic anemia (AIHA) 1
  • Initiate prednisone 1-2 mg/kg/day immediately 1
  • Consider transfusion only if hemoglobin <7-8 g/dL or patient is symptomatic 1
  • Monitor weekly until stabilized 1
  • If no response after 3 weeks, escalate to rituximab, IVIG, or splenectomy 1

In neonates, a positive DAT confirms:

  • Hemolytic disease of the newborn from maternal-fetal blood group incompatibility 4, 2

Negative DAT

A negative DAT is normal in healthy individuals and excludes classic autoimmune hemolytic anemia 7, 1

When DAT is negative but hemolysis is present, redirect diagnosis toward:

Non-Immune Hemolysis

  • Examine peripheral smear for schistocytes (suggests thrombotic microangiopathy) 7, 1
  • Hereditary spherocytosis 1
  • G6PD deficiency 1
  • Mechanical hemolysis from prosthetic heart valves 1

Atypical Hemolytic Uremic Syndrome (aHUS)

  • The combination of thrombocytopenia, hemolysis with schistocytes, renal dysfunction, and negative DAT strongly suggests aHUS 6, 7
  • This is a diagnostic criterion for aHUS 7
  • Requires urgent evaluation for complement-mediated thrombotic microangiopathy 6, 7

Critical Pitfalls and Technical Considerations

False-Negative Results

Low-affinity IgG antibodies can dissociate during routine room-temperature washing, causing false-negative DAT despite significant in vivo hemolysis 9

To avoid missing these cases:

  • Use cold-washed (4°C) red blood cells when DAT is negative but clinical suspicion for AIHA remains high 9
  • Consider gel column methods (DiaMed system) that use unwashed cells and are more sensitive for low-affinity antibodies 9
  • An eluate prepared from cold-washed cells may reveal IgG autoantibodies even when standard DAT is negative 9

False-Positive Results

Technical errors causing false positivity include 3, 5:

  • Improper washing technique
  • Incorrect centrifugation
  • Spontaneous red blood cell agglutination
  • Over-agitation during interpretation

Context-Dependent Interpretation

The DAT result must always be interpreted alongside clinical findings and other laboratory data 3, 5:

  • A positive DAT without hemolysis may represent clinically insignificant antibody binding
  • A negative DAT does not exclude hemolysis—it redirects the differential diagnosis 1

Diagnostic Algorithm

  1. Confirm hemolysis: Check LDH, indirect bilirubin, haptoglobin, reticulocyte count 7, 1
  2. Order DAT to determine immune vs. non-immune etiology 1
  3. If DAT positive: Diagnose immune-mediated hemolysis and initiate corticosteroids 1
  4. If DAT negative with hemolysis:
    • Examine peripheral smear for schistocytes 7, 1
    • Evaluate platelets and renal function (thrombocytopenia + renal dysfunction + negative DAT = consider aHUS) 6, 7
    • Consider hereditary hemolytic anemias or mechanical causes 1
    • If high clinical suspicion for AIHA persists, repeat DAT with cold-washed cells 9

References

Guideline

Diagnostic Approach to Hemolysis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

How to use: the direct antiglobulin test in newborns.

Archives of disease in childhood. Education and practice edition, 2015

Guideline

Rh Antibody Titre and Direct Coombs Test in Maternal-Fetal Medicine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls.

Archives of pathology & laboratory medicine, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretación y Aplicaciones del Coombs Directo Negativo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The dot blot direct antiglobulin test.

American journal of clinical pathology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.